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A Role for Hematopoietic Stem Cells
in Promoting Angiogenesis
cesses, bidirectional signaling between endothelial cells
(ECs) and the surrounding mesenchymal cells is critical
(Folkman and D'Amore 1996). Many molecules have
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A first step in angiogenesis in the adult vessel is disso-Japan
ciation of periendothelial cells (pericytes) tightly adher-
ing to ECs. The balance between adhesion and dissocia-
tion of ECs and pericytes depends on angiopoietins,
the ligands for TIE2. Angiopoietin-1 (Ang1) deficient em-Summary
bryos show severe vascular abnormalities, as observed
in TIE2 deficient embryos. These abnormalities includeAngiogenesis is an important event for embryonic or-
insufficient branching of the cardinal vein or capillariesganogenesis as well as for tissue repair in the adult.
in the pericardium, lack of remodeling of vessels in theHere, we show that hematopoietic stem cells (HSCs)
yolk sac, and insufficient heart development (Suri etplay important roles for angiogenesis during em-
al., 1996). Moreover, ultrastructural analysis reveals thatbryogenesis. To investigate the role of HSCs in endo-
close adhesion between ECs and pericytes is inhibitedthelial cell (EC) development, we analyzed AML1-defi-
in the absence of TIE2 or Ang1. A naturally occurringcient embryos, which lack definitive hematopoiesis.
antagonist of Ang1, designated Ang2, blocks the abilityThese embryos showed defective angiogenesis in the
of Ang1 to activate TIE2 (Maisonpierre et al., 1997).head and pericardium. Para-aortic splanchnopleural
Transgenic mice expressing Ang2 exhibit phenotypes(P-Sp) explant cultures on stromal cells (P-Sp culture)
similar to those observed in TIE2 or Ang1 deficient em-did not generate definitive hematopoietic cells and
bryos (Maisonpierre et al., 1997). Thus, while Ang1 isshowed defective angiogenesis in the AML1 null em-
expressed in mesenchyme surrounding large vessels inbryo. Disrupted angiogenesis in P-Sp cultures from
the embryo and is widely expressed in the adult, Ang2AML1 null embryos was rescued by addition of HSCs
is expressed only at sites of vascular remodeling (Mai-or angiopoietin-1 (Ang1). HSCs, which express Ang1,
sonpierre et al., 1997). This observation suggests thatdirectly promoted migration of ECs in vivo and in vitro.
Ang2 blocks an otherwise constitutive stabilizing signalThese results indicate that HSCs are critical for angio-
by Ang1 and promotes localized vessel destabilization.genesis.
Destabilization of vessels by Ang2 may contribute to
either vessel regression by blocking factors required for
Introduction survival of ECs produced by pericytes or new vessel
sprouting. Prolonged overexpression of Ang2 without
Vascular development consists of two different pro- VEGF promotes vessel regression, although vessel sprout-
cesses, vasculogenesis and angiogenesis. In both pro- ing occurs when Ang2 and VEGF are coexpressed (Asa-
hara et al., 1998; Holash et al., 1999).
Recently, we found that Ang1 stimulated integrin-k To whom correspondence should be addressed (e-mail: sudato@
gpo.kumamoto-u.ac.jp [T. S.]; ntakaku@gpo.kumamoto-u.ac.jp [N. T.]). dependent adhesion of TIE2 expressing cells to fibro-
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Figure 1. P-Sp Culture System Supports Vas-
culo-angiogensis and Hematopoiesis
(A) The development of ECs in P-Sp cultures
from E9.5 mouse embryos. Culture plates
were fixed after 2 (a,d,e, and f), 4 (b), and 8
(c,g,h, and i) days of culture, and stained with
anti-PECAM-1 (a±d and g), -Flk-1 (e and h),
or -TIE2 (f and i) mAbs, respectively. (d) and
(g) are the higher maginification of areas of
(a) and (c) indicated by the dashed box, re-
spectively. Migrating ECs from the explant
highly expressed PECAM-1 (arrowhead in d)
or Flk-1 (arrowhead in e). TIE2 expression was
faint in migrating ECs (arrowhead in f) or vb
(arrowhead in i), although it was strong in
sprouting ECs (arrows in f and i). Isotype
matched control IgG showed no staining in
the cells of this P-Sp (data not shown). Abbre-
viations: vb, vascular bed; vn, vascular net-
work. Scale bars: (a±c) 400 mm; (d±j) 133 mm.
(B) Hematopoiesis in P-Sp cultures. Cells
from P-Sp cultures on OP9 cells were har-
vested at indicated days, and the number of
HCs was counted after removal of adherent
cells by Sephadex G10. Subsequently, cells
were transferred to methylcellulose semisolid
culture. The number of progenitor cells form-
ing a colony was counted after 7 days of
culture.
nectin or collagen (Takakura et al., 1998; Sato et al., Results
1998). This role is consistent with the close adhesion
between ECs and pericytes promoted by Ang1. How- Vasculo-angiogenesis in the P-Sp Culture System
ever, it has been reported that Ang1 promotes vessel To characterize the interaction between ECs and hema-
sprouting by acting as a chemoattractant. (Witzen- topoietic cells (HCs), an in vitro culture system for vas-
bichler et al., 1998). Vessel sprouting begins with disso- culo-angiogenesis and hematopoiesis was developed.
ciation of pericytes from ECs, a process mediated by P-Sp explants from the E9.5 embryos were cultured on
inactivation of Ang1 signaling. Subsequently, ECs may OP9 stromal cells. In this culture, PECAM-11 ECs form a
sprout toward Ang1-producing tissues. As recruitment sheet-like structure (vascular bed, vb) and subsequently
of pericytes is followed by migration of ECs, Ang1-pro- form a network (vascular network, vn) in the periphery
ducing cells may promote vessel sprouting at a distance. of the endothelial sheet. To analyze vasculo-angiogen-
To examine the angiogenesis mediated by TIE2±angio- esis in this culture system, EC growth was observed
poietin system, we established a new culture system using the markers PECAM-1, Flk-1, and TIE2. At the
supporting angiogenesis and hematopoiesis using the early stages of culture, PECAM-1- and Flk-1-positive
para-aortic splanchnopleural (P-Sp) region (pre-AGM ECs were generated from the P-Sp explant. These cells
region; aorta-gonad-mesonephros region), a site where migrated and formed a circle around the explant on OP9
definitive HSCs are committed from hemangioblasts cells (Figure 1A, a,d, and e). TIE2 expression was weak
(Cumano et al., 1996; Medvinsky and Dzierzak, 1996). in migrating ECs, although sprouting ECs in the circle
Here, we show that Ang1 derived from HSCs promotes expressed TIE2 strongly (Figure 1A, f). Subsequently,
vessel sprouting into avascular areas and that this stim- PECAM-1-, Flk-1-positive ECs surrounding the explant
ulation is critical in tissues where Ang1-producing mes- proliferated and formed a vascular bed, and a large
enchymal cells are absent. Moreover, we demonstrate number of ECs sprouted from the vascular bed and
that HSCs are required for angiogenesis by presenting formed network-like structure (Figure 1A, b, c, g, and
h). Compared with the weak expression of TIE2 in ECsa detailed histological analysis of capillary formation in
AML1 deficient mice, which lack HSCs completely. in the vascular bed, sprouting ECs highly expressed TIE2
HSCs Promote Angiogenesis
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(Figure 1A, i). Inhibition of Flk-1 signaling by addition of
soluble Flk-1 receptors to the culture disrupted forma-
tion of both the vascular bed and network of ECs, and
addition of soluble TIE2 inhibited network formation of
ECs (Takakura et al., 1998). In this culture system, we
define vasculogenesis as the process in which PECAM-
11Flk-11TIE2low immature ECs migrate from the explant
and form a vascular bed. Angiogenesis is defined as
the process of sprouting of PECAM-11Flk-11TIE21 ECs
from such a bed and subsequent network formation.
The development of HCs was observed in this culture
system. HCs, which were initially observed in the periph-
ery of the vascular bed, migrated into the vascular
network area and proliferated. As the number of HCs
increased, erythroid, granulocyte-macrophage, and
lymphoid progenitor cells increased on days 6±10 of
culture (Figure 1B).
Lack of Hematopoiesis and Angiogenesis in P-Sp
Cultures from AML1 Deficient Mice
AML1 deficient mice provide a tool to analyze the inter-
action between hematopoiesis and angiogenesis. Dis-
ruption of AML1 leads to failure in the development of
definitive hematopoiesis and lethality at E12.5 (Okuda
et al., 1996; Wang et al., 1996). Mutant embryos exhibit
hemorrhages in the ventricles of the central nervous
system and in the vertebral canal and within the pericar-
dial space and peritoneal cavity. We analyzed the vascu-
lar development of AML1 deficient mice (Okada et al.
1998) in vivo and in vitro. Whole mounts of E11.5 em-
bryos were stained with the PECAM-1 monoclonal anti-
body (mAb) to visualize all ECs. Mutant embryos were
Figure 2. Defective Angiogenesis in AML1 Mutant Embryosthe same size as wild-type (wt) embryos at E11.5 (Fig-
(A) Whole-mount PECAM-1-stained wt and AML1 mutant embryosure 2A). The analysis showed that extensive vascular
at E11.5. (B±E) High power views of (A).branching and remodeling into large and small vessels
(B and D) Wild-type and (C and E) mutant embryos. Arrowhead or
occurred normally in the head region of both wt and arrow in (B) indicates highly branched small capillary in the hindbrain
mutant embryos by E11.5. However, the number of small or network forming cardinal vein, respectively. Counterparts in mu-
capillaries in mutant embryos (Figure 2C) was less in the tant (C) show less branching or less caliber change of vessels. A
hindbrain than that observed in wt (Figure 2B); moreover, network of capillaries surrounded the pericardium (arrowheads) in
wt heart (D), while comparable network formation was absent inlarge vessels in the mutant embryo (Figure 2C) contained
mutants (E). Abbreviations: v, ventricles; a, atrium.fewer branches than those seen in wt embryos (Figure
(F and G) Yolk sac vascularization. Note less branching of the vitel-2B). In mutant embryos, less branching of capillaries
line artery in mutants (G, arrowheads) compared to wt embryos (F,was observed in vessels of the pericardium (Figures 2D
arrowheads). Gross appearance of the wt (H) and mutant (I) headsand 2E) and in the vitelline artery of the yolk sac (Figures
of E11.75 embryos. Hemorrhage (arrow) and aneurysm (arrowhead)2F and 2G). Consistent with defective angiogenesis in
was observed in the mutants.
the head, massive hemorrhages and aneurysms were
observed in mutant embryos (Figure 2I). Such abnormal-
ities were not seen in wt embryos (Figure 2H).
small number of HCs and thereby provide a model inTo analyze the interaction between HSCs and ECs,
which the effect of an intermediate number of HCs onwe observed the development of ECs in P-Sp cultures
angiogenesis can be tested. As expected, c-Myb mutantfrom AML1 mutant embryos. As expected, HCs were not
explants contained smaller populations of HCs than didgenerated from P-Sp explants of AML1 mutant embryos
explants derived from wt embryos. c-Myb mutant-(Figure 3A, b and d). In contrast, explants from wt em-
derived P-Sp cultures contained megakaryocytes andbryos developed many round cells adhering to the pre-
monocyte/macrophages, but no erythroid cells (data notsumptive vascular network area (Figure 3A, a and c).
shown). Moreover, the number of hematopoietic pro-Cells harvested from cultures derived from wt embryos
genitor cells in c-Myb mutant cultures was a hundred-formed several hematopoietic colonies in a semisolid
fold less than that observed in wt explants (Table 1). Inmedium; however, AML1 mutant embryos did not gener-
proportion to the number of HCs, the area of the vascularate hematopoietic progenitor cells in these conditions
network was reduced in cultures of c-Myb mutant ex-(Table 1). After fixation of the culture plate, we examined
plants (Figure 3B).the development of ECs. The wt explant generated vas-
cular beds and networks (Figure 3A, e); on the other
HCs Promote Angiogenesis in P-Sp Cultureshand, poor vascular network formation was observed
To test the hypothesis that HCs promote angiogenesis,in cultures of AML1 mutant explants (Figure 3A, f).
HSC-enriched population from the bone marrow ofTo evaluate further the effect of HCs on angiogenesis,
transgenic mice harboring green fluorescent proteinwe examined explants from c-Myb mutant embryos (Mu-
censki et al., 1991). c-Myb mutant embryos generate a (GFP) under the transcriptional control of the b actin
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in bone marrow HSC-enriched population (Lin2c-
Kit1Sca-11) but not in mature HCs (CD451Lin1). During
embryogenesis, CD451c-Kit1CD341 cells are defined as
HSCs (Yoder et al., 1997). As observed in the bone mar-
row, CD451c-Kit1CD341 cells highly expressed Ang1
but not VEGF. Other angiogenesis related genes such
as Ang2 and ephrinB2 were not expressed in either
mature or immature HCs (data not shown). To clarify
whether an HSC-enriched population produces Ang1
as a protein, we sorted HSC-enriched population from
E12.5 fetal liver and adult bone marrow of mice heterozy-
gous for Ang1-targeted allele in which b-galactosidase
(LacZ) expression is under control of Ang1 promoter
(Suri et al., 1996) and examined the expression of Ang1
and LacZ (Figures 5B and 5C). We detected Ang1 protein
in HSC-enriched population (Figure 5B, a and c) by anti-
Ang1 antibody but not in mature HCs (Figure 5B, b and
d). The frequency of Ang1 positive cells was 90% in
CD451c-Kit1CD341 cells of the fetal liver, and 50% in
Lin2c-Kit1Sca-11 cells of adult bone marrow. Moreover,
we confirmed that LacZ positive cells in HSC-enriched
population were detected at a similar frequency to that
observed in Ang1 expression (data not shown). Finally,
the LacZ gene was expressed in HSC-enriched popula-
tion abundantly in an mRNA level by RT-PCR analysis
(Figure 5C). To determine whether HSCs participate in
angiogenesis, we examined whether HSCs exist in the
head region where severe angiogenic defects are ob-
served in the AML1 mutants. At E10.5, the primary sites
of hematopoiesis have been reported to be in the yolk
sac and AGM region (Medvinsky and Dzierzak, 1996;
Yoder et al. 1997). To examine the localization of HSCs,
embryos at E10.5 were dissected into three parts: the
yolk sac, AGM region, and head. The surface phenotype
of dissociated cells was analyzed by FACS (Figure 5D).
CD451 HCs were divided into CD341c-Kit1 cells and
Figure 3. Requirement of HSC Development for Angiogenesis In CD34dull/2c-Kitdull/2 cells. The frequency of CD341c-Kit1
Vitro cells in the head was low compared with that observed
P-Sp explants from (A) wt (a, c, and e) and AML1 mutants (b, d, and in the yolk sac and AGM region. Limiting dilution of
f) or (B) wt (a and c) and c-Myb mutants (b and d) were dissected CD341c-Kit1 cells or CD342c-Kit2 cells cocultured with
at E9.5, and cultured on OP9 cells. (A) Phase contrast microscopy OP9 cells revealed that multipotential hematopoietic
(a±d). (c) and (d) are the higher magnification of areas of (a) and (b) progenitors were included in the CD341c-Kit1 fraction
indicated by the box, respectively. (e and f) P-Sp cultures stained but not in the CD342c-Kit2 fraction. Moreover, the inci-
with anti-PECAM-1 mAb. Scale bars: (a, b, e, and f) 200 mm; (c and
dence of hematopoietic progenitors in CD341c-Kit1d) 50 mm. (B) Phase contrast microscopy demonstrates that the
cells was not different in the yolk sac, AGM region,number of round cells in c-Myb mutant cultures (b) was less than
and head (Figure 5D). These findings indicate that HSCsthat observed in wt culture (a). (c and d) P-Sp cultures stained with
migrated to the head after circulation was established.anti-PECAM-1 mAb. Scale bar: 50 mm.
Ang1 on HSCs Plays an Important Role in Vascular
promoter (Okabe et al., 1997) was sorted by flow-cytom- Network Formation
etry and added to P-Sp cultures of AML1 mutant em- These findings suggested that Ang1 expressed on HCs,
bryos. In these transgenic mice, all tissues except eryth- especially HSC-enriched populations, promotes angio-
rocytes and hair fluoresce, allowing us to visualize genesis. To test this hypothesis, we added CD451c-
precisely the morphology of nonmutant cells. As ex- Kit1CD341 cells from E10.5 Ang1 mutants and wt em-
pected, addition of HSCs rescued defective angiogen- bryos to P-Sp cultures of AML1 mutant embryos. As
esis in AML1 mutant embryos (Figure 4A, b and c). The observed in bone marrow HSCs (Figure 4A), CD451c-
fine vascular network coincides with the region where Kit1CD341 cells from wt embryos rescued defective net-
HCs formed a colony (Figure 4A, a). Their round morphol- work formation of ECs (Figure 4B, a); however, the same
ogy confirmed that exogenous HCs did not differentiate number of HSC-enriched cells from Ang1 mutant em-
into elongated ECs (Figure 4A, d). bryos could not (Figure 4B, b). Moreover, when soluble
TIE2 receptors or Ang2 were added simultaneously with
HSCs enriched from wt embryo to inactivate Ang1 sig-Ang1 Expression in HSCs
Since results from the P-Sp culture system suggested naling via TIE2 in P-Sp cultures, HSC-mediated rescue
of defective angiogenesis of AML1 mutants was com-that extrinsic signals from HCs promote angiogenesis,
we searched for factors that could mediate this process. pletely abolished (data not shown). To test whether Ang1
alone rescues the angiogenic defects observed in AML1As shown in Figure 5A, Ang1 and VEGF were expressed
HSCs Promote Angiogenesis
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Table 1. Hematopoietic Progenitors in Cultured P-Sp Explants
AML1 Colonies per explant
Wild type Heterozygote Homozygote
Erythroid GM Erythroid GM Erythroid GM
118 6 4 1580 6 90 100 6 4 1292 6 132 0 6 0 0 6 0
c-Myb Colonies per explant
Wild type Heterozygote Homozygote
Erythroid GM Erythroid GM Erythroid GM
108 6 17 1034 6 55 109 6 13 1006 6 76 0 6 0 14 6 8
P-Sp from AML-1 or c-Myb 1/1, 1/2, and 2/2 E9.5 embryos were cultured on OP9 cells for 10 days. Non adherent cells were then assayed
for hematopoietic colonies in semisolid media using methylcellulose supplemented with IL-3, SCF, and Epo. The number of hematopoietic
colonies was scored after 7 days in culture. The total number of colonies (.40 cells) per explant was obtained from three independent
experiments and expressed as the mean 6 SEM (n 5 3). ªErythroidº indicates a colony containing definitive erythrocytes. ªGMº indicates a
colony containing granulocytes and/or macrophages.
mutants, Ang1* (see Experimental Procedures) was and g) embryos, round cells, which were lacking in the
AML1 mutants (Figure 6B, d and l), expressed Ang1added to P-Sp cultures derived from AML1 mutant em-
bryos. 100 ng/ml Ang1* did not rescue the angiogenic highly (Figure 6B, c and k) in wt embryos. Those round
cells were located outside the lumen of the vessel andphenotype effectively (data not shown); however, 300
ng/ml Ang1* promoted angiogenesis to a level equiva- expressed CD45 (Figure 6B, i). CD451 cells were not
seen in AML1 mutants (Figure 6B, j), indicating thatlent to wt (Figure 4B, d). Interestingly, addition of the
same amount of Ang1* to P-Sp cultures of wt embryos round cells expressing Ang1 and CD45 are HCs.
altered the morphology of the vascular bed to a lattice-
like network structure (Figure 4B, c, arrow). It is assumed HSCs Regulate Vascular Network Formation
that AML1 or cMyb mutant embryos expressed Ang2 at To examine the effect of HSCs in angiogenesis, we com-
higher levels than did wt embryos; however, there was pared capillary formation of wt and AML1 mutant em-
no upregulation of Ang2 mRNA expression in P-Sp re- bryos in the E10.5 brain ectoderm. In wt embryos, ini-
gions and whole embryos from AML1 or cMyb mutants. tially, ECs seemed to migrate toward CD451 HCs in
the neuronal layer (Figure 7A, a). These CD451 cells
migrating in front of ECs also expressed c-Kit or CD34Ang1 Expression in Pericytes and HCs
It has been reported that periendothelial cells such as (data not shown), indicating that CD451 cells are in the
HSC population. After ECs formed a network, HSCs re-pericytes and smooth muscle cells constitutively se-
crete Ang1 (Davis et al., 1996). We analyzed the expres- mained near ECs (Figure 7A, b), as observed in the P-Sp
culture (Figure 6A, g). In E10.5 AML1 mutants, ECs mi-sion of Ang1 in the P-Sp culture system and in vivo.
First, to determine whether pericytes exist in P-Sp cul- grating into the ectodermal layer showed disorganized
structures. For example, many pods sprouted from onetures, we looked for a smooth muscle actin (aSMA)-
positive cells. We observed two types of vascular beds capillary (Figure 7A, c), and ECs did not form tube-like
structures, leading to hemorrhage in the ectoderm (Fig-marked by the presence or absence of aSMA1 cells. One
was a lattice-like vascular bed that was aSMA positive ure 7A, d).
Next, to test whether HSCs promote angiogenesis(Figure 6A, a; box by dashed line and b). The other was
a smooth monolayer of ECs that was aSMA negative. in vivo, we used a method for assessing angiogenesis
requiring reconstituted basement membrane (PassanitiBased on distribution of PECAM-11 cells, the sprouting
of ECs did not appear to depend on aSMA1 cells (Figure et al., 1992). An HSC-enriched population sorted from
adult bone marrow was prestained with PKH26 red fluo-6A, c). Ang1 expression was detected in two cell types.
One type was umbrella shaped (Figure 6A, d), and these rescence and mixed with matrigel in the presence or
absence of soluble TIE2 receptors. Gels were injectedcells also expressed aSMA (data not shown). The other
type was round HCs (Figure 6A, e) and hematopoietic subcutaneously into the abdominal region of adult mice.
Matrigel mixed with HSCs without soluble TIE2 recep-clusters showing a cobble stone appearance (Figure 6A,
f). Consistent with the area in which HCs express Ang1, tors (Figure 7B, a) appeared yellow, suggesting a large
number of erythrocytes within the gel. On the other hand,PECAM-11 ECs migrated from the vascular bed (Figure
6A, g) and formed a network. matrigel mixed with HSCs with soluble TIE2 receptors
appeared white (Figure 7B, c). In the section, PECAM-1As observed by in situ hybridization analysis (Suri et
al., 1996), Ang1 expression was detected in myocardial labeled ECs were localized near PKH26-labeled HSCs
and formed a capillary network as observed in the neu-cells (Figure 6B, a±d), periendothelial cells surrounding
large vessels (Figure 6B, e±h), and mesenchymal cells ronal layer (Figure 7A, b). Soluble TIE2 receptors inhib-
ited this network of ECs (Figure 7B, d). Gels withoutin the intersomite region (data not shown) of E10.5 em-
bryos. Consistent with a lack of aSMA1 periendothelial HSCs or with Lin1 mature HCs could not promote capil-
lary formation (data not shown). Taken together, thecells, we did not detect Ang1 expression in mesenchy-
mal cells surrounding small vessels at this stage; how- data suggests that HSCs promote migration of ECs
through TIE2 and contribute to EC network formation inever, some mesenchymal cells not adhering to vessels
expressed Ang1 (data not shown). Although overall, vivo.
Finally, we investigated the migration of ECs sortedthere is little difference in Ang1 expression between
AML1 mutant (Figure 6B, d and h) and wt (Figure 6B, c from E10.5 embryos (Figure 7C, a) induced by Ang1
Cell
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Figure 4. Rescue of Defective Angiogenesis in AML1 Mutant P-Sp
Cultures
(A) Rescue of defective angiogenesis in AML1 mutants by HSCs
enriched from adult bone marrow. (a) Phase contrast microscopy
shows that exogenous HSCs form hematopoietic colonies beside
Figure 5. Expression of Ang1 on HC and Existence of HSCs in thethe vascular bed (vb) of AML1 mutant P-Sp cultures. (b) PECAM-1
Head of E10.5 Embryosstaining in (a). (c) A high power view of the area indicated by the
dashed box in (b). (d) Detection of GFP-positive cells by fluores- (A) Analysis of growth factor mRNA expression in HCs from adult
cence microscopy in (c). Scale bars: (a and b) 250 mm; (c and d) bone marrow or E10.5 embryos by reverse transcriptase-PCR.
67 mm. CD451Lin1; mature HCs, CD451Lin2; immature HCs, Lin2c-Kit1
(B) Rescue of defective angiogenesis in AML1 mutants by HSCs Sca-11; HSC-enriched population, CD452TER1191; primitive eryth-
from embryos (a and b) or Ang1 (c and d). HSC-enriched populations rocytes, CD451TER1192; HCs other than primitive erythrocytes,
from E10.5 wt (a) or Ang1 mutant (b) embryos from the same litter CD451c-Kit2CD342; mature HCs, CD451c-Kit1CD341; and HSC-
were added to the AML1 mutant P-Sp culture. Three hundred nano- enriched population. b actin mRNA served as a loading control.
grams per milliliter of Ang1* was added to the P-Sp culture of wt (B) Production of Ang1 on HSC-enriched population. CD451c-
(c) and AML1 mutant (d) embryos. A lattice-like structure (arrow in Kit1CD341 cells (a) and CD451c-Kit2 CD342 cells (b) sorted from
c). Scale bars: (a and b) 125 mm; (c and d) 250 mm. E12.5 fetal liver of mice heterozygous for Ang1-targeted allele
(Ang11/2) in which b galactosidase (LacZ) expression is under con-
trol of Ang1 promoter, and Lin2c-Kit1Sca-11 cells (c) and Lin1 cells
(d) from adult bone marrow of Ang11/2 mouse were stained by anti-or HSCs. Ang1* led to a dose-dependent increase in
Ang1 antibody. Ang1 expression is visualized as a dark blue reaction
directed migration of TIE21 ECs but did not promote product. Nuclei were stained with nuclear fast red. Scale bar: 20mm.
migration of control CD452PECAM-12TIE22 cells (Fig- (C) mRNA expression of LacZ on sorted HCs. Lanes (a)±(d) correlate
ure 7C, b). Ang2 did not stimulate chemotactic activity with that described in Figure 5B.
(data not shown). CD451c-Kit1CD341 HSCs from E10.5 (D) Incidence of HSCs in E10.5 embryos. Cells from the AGM region,
yolk sac, or head region from E10.5 embryos were stained withembryos also promoted migration of TIE21 ECs in a
anti-CD45, CD34, and c-Kit mAbs and analyzed by flow cytometry.dose-dependent manner. This migration was com-
CD451 cells were gated (left histogram, percentages of CD451 cellspletely suppressed by soluble TIE2 receptors (TIE2-Fc)
are indicated in the panel), and examined for expression of CD34but not by CD4-Fc control protein or by soluble Flk-1
and c-Kit (middle panel, percentages of each fraction are indicatedreceptors (Flk-1-Fc). CD451c-Kit2CD342 mature HCs
in the upper right quadrant). Sorted CD451c-Kit1CD341 cells or
also promoted migration of TIE21 ECs, but less effi- CD451c-Kit2CD342 cells were evaluated by a limiting dilution assay
ciently than did HSCs. Moreover, migration of ECs stim- for their ability to differentiate into multiple hematopoietic lineages.
ulated by mature HCs was also blocked by soluble TIE2 The frequency of multipotential hematopoietic progenitors in
receptors (Figure 7C, c). These findings indicate that CD451c-Kit1CD341 cells was 1/2.6 (AGM), 1/2.4 (yolk sac), or 1/3.2
(head) according to a Poisson analysis.HSC-induced migration of TIE21ECs depends on Ang1.
HSCs Promote Angiogenesis
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Figure 6. Localization of Smooth Muscle
Cells and Expression of Ang1 in P-Sp Cul-
tures and Embryonic Tissues
(A) (a±c) P-Sp explants cultured on OP9 cells
for 10 days were stained with anti-PECAM-1
mAb (blue) and anti-a smooth muscle actin
(aSMA) mAb (brown). (b and c) High-power
view of the dashed (b) or solid (c) box in (a),
respectively. (d±f) P-Sp explants cultured as
above were stained with anti-Ang1 antibody.
(d) Umbrella-shaped pericytes in the vascular
bed were positive for Ang1. Round HCs (e)
and hematopoietic clusters (f) on the vascular
network were also Ang1-positive. (g) PECAM-1
(blue) and Ang1 (red) expression. Arrowheads
indicate PECAM-11 ECs. Scale bars: (a) 500
mm; (c and d) 125mm; (d, f, and g) 40 mm; (e)
25 mm.
(B) Ang1 expression in tissues of E10.5 em-
bryos. (a±d) the heart, (e±h) dorsal aorta, and
(i±l) head from wt (a, c, e, g, i, and k) or AML1
mutants (b, d, f, h, j, and l). (a, b, e, and f)
Double staining with anti-PECAM-1 (blue)
and anti-aSMA (brown) mAbs. abbreviations:
c, capillary; ec; endothelial cells, mc; myocar-
dial cells, pc; pericardial cells, smc; smooth
muscle cells. (c, d, g, h, k, and l) Ang1 expres-
sion. Ang1 expression was detected in mc
and smc from both AML1 mutant and wt em-
bryos. Round HCs express Ang1 (arrows in c
and k). (i and j) Double staining with anti-CD45
(red) and PECAM-1 (blue) mAbs. Scale bar:
40 mm.
Discussion in the P-Sp culture system. In AML1 mutant embryo,
many vessels are present at locations where Ang1 ex-
pression is normally observed in mesenchymal cell com-In this paper, we develop the P-Sp culture system to
partment. Histological analysis revealed that capillaryanalyze HSC function and present a model that HSCs
formation is dependent on Ang1 from HSCs in an areapromote angiogenesis through Ang1. Stem cells may
where Ang1-producing mesenchymal cells are absent.have a capacity to contribute to tissue organization
Based on observations of capillary formation in neuronalthrough specific cytokines. To clarify the interaction be-
layers, HSCs appear to determine the direction of vesseltween HSCs and ECs, we used AML1 mutant embryos,
sprouting, since migration of ECs in AML1 mutant em-which do not generate definitive HSCs and exhibit de-
bryos is severely disorganized. In addition, vascularfective vasculature in vivo. We demonstrate defective
phenotypes in AML1 mutants, such as poor branchingangiogenesis in P-Sp explants cultured from these em-
of the cardinal vein in the head and poor network forma-bryos and show that this defect is secondary to hemato-
tion in the pericardium, are quite similar to those ob-poietic failure.
served in Ang1 mutant embryos (Suri et al., 1996). HSCsIn P-Sp cultures from wild-type embryos, two types
derived from wt embryos or adult bone marrow rescueof vascular bed formation are observed. One is a lattice-
angiogenesis defects seen in AML1 mutants in the P-Splike bed in which aSMA1 cells adhering to ECs express
culture, but HSCs derived from Ang1 mutant embryosAng1; the other is a smooth vascular bed that lacks
can not, indicating that HSC-derived Ang1 is critical foraSMA1 cells. Since Ang1 expressed on pericytes pro-
angiogenesis.motes vessel remodeling (Suri et al., 1996), the presence
of pericytes may promote formation of fine networks
in the vascular bed in an Ang1-dependent manner, as Role of AML1 in Vasculo-angiogenesis
Mutations in several genes, such as Scl (Robb et al.,observed in vivo. Moreover, we do not observe aSMA1
cells in regions of the vascular network where extensive 1995; Shivdasani et al., 1995a), flk-1 (Shalaby et al.,
1995), and TIE2 (Dumont et al., 1994; Sato et al., 1995,sprouting of ECs occurs. During early embryogenesis,
capillary formation proceeds without pericytes. Expres- Takakura et al. 1998), affect both endothelial and hema-
topoietic cell development. These genes are expressedsion of Ang1 is not always observed in mesenchymal
cells around capillaries. Sprouting of new vessels in the in both lineages. It is important to determine whether
the effects of mutations in these genes on endothelialhead and pericardium is analogous to sprouting of ECs
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Figure 7. Vessel Sprouting by HSCs
(A) Sections from E10.5±E11.5 embryos dou-
ble stained with anti-CD45 (red) and anti-
PECAM-1 (blue) mAbs. Vessels in the brain
ectodermal layer of wt (a and b) or AML1
mutant (c and d) embryos. Note that ECs in
the AML1 mutant embryo sprouted in many
directions (arrowheads) from one capillary (c).
(d) Disorganized capillaries lead to hemor-
rhage in AML1 mutants. Inset shows hema-
toxylin-eosin staining in the box. Scale bar:
25 mm.
(B) HSCs promoted capillary sprouting in
adult mice. Matrigels containing HSCs and
CD4-Fc chimeric protein (a and b) or HSCs
and soluble TIE2 receptors (c and d) were
injected subcutaneously near the abdominal
midline. (a and c) Appearance of matrigels on
day 4. (b and d) Fluorescence microscopic
analysis of sections from matrigels. HSCs
were labeled with PKH26 (red) before mixing
with gels. ECs were visualized as green
following staining with FITC-conjugated
PECAM-1 mAb. Scale bar: 50 mm.
(C) Migration of ECs induced by Ang1 or
HSCs. (a) Cells from total embryos at E10.5
stained with anti-CD45, -PECAM-1, and -TIE2
mAbs were analyzed by flow cytometry.
After gating the CD452 fraction (left panel),
CD311TIE21 cells (indicated by box in right
panel) or CD312TIE22 cells used as negative
controls were sorted. (b) Diluted Ang1* (0±500 ng/ml) was applied to the lower chamber. A total of 4 3 102 cells/well were seeded into the
upper chamber, and cells were allowed to migrate for 4 hr. (c) CD451c-Kit1CD341 cells or CD451c-Kit2CD342 cells were sorted as above
(Fig. 5C) and seeded into the lower chamber in the presence or absence of the factors indicated. A total of 4 3 102 CD452CD311TIE21 ECs
were applied to upper chamber and allowed to migrate for 4 hr.
and hematopoietic cells are primary or secondary. Re- clearly rescued by HSCs in the P-Sp culture system.
This finding suggests that disorganized EC developmentcently, an analysis of Scl gene function was reported
(Visvander et al., 1998). Through transgenic rescue of and hemorrhage seen in AML1 mutant embryos are sec-
ondary effects due to a lack of definitive HSCs.hematopoietic defects of Scl mutant embryos and analy-
sis of chimeras generated with Scl null ES cells tagged
with a transgene expressed in vascular ECs, SCL was
shown to affect EC development primarily. HSCs Promote Vessel Sprouting
An important question in vasculo-angiogenesis, espe-AML1 encodes the DNA binding subunit of a transcrip-
tion factor of the core binding factor family. Members of cially in vessel sprouting, is how ECs migrate to sites
where tissues require nutrients or oxygen. Although find-this family are thought to regulate expression of several
genes, such as the T cell antigen receptor, myeloperoxi- ings shown here indicate that ECs migrate toward Ang1
producing HSCs, the basic mechanism of how HSCsdase, granulocyte-macrophage colony stimulating fac-
tor, interleukin-3, and colony stimulating factor receptor migrate from the intraluminal cavity into parenchymal
cells at a restricted point of a vessel is unclear. A report1 (Tenen et al., 1997). Consistent with these observa-
tions, homozygous disruption of the AML1 gene se- that peripheral CD341 hematopoietic progenitors ex-
press high levels of matrix metallo-proteinases (MMP)-2verely impairs definitive hematopoiesis but does not
affect primitive erythropoiesis (Okuda et al., 1996; Wang and -9 (Janowska-Wieczorek et al., 1999) may shed light
on this mechanism. Our preliminary data also show thatet al., 1996; Okada et al., 1998). The reason for the lethal
hemorrhage observed in AML1 mutant embryos is not embryonic HSCs (CD451c-Kit1CD341 cells) express
MMP-9 strongly (data not shown). Moreover, theseunderstood. Initially, platelet deficiency was thought to
lead to hemorrhage; however, mice mutant in the NF- HSCs express TIE2 and adhere to fibronectin (FN) fol-
lowing stimulation by Ang1 (Takakura et al., 1998). TakenE2 gene exhibit severe defects in platelet development
but do not hemorrhage at early embryonic stages (Shiv- together, these results suggest that HSCs adhere to FN
on ECs near the ischemic region, digest the matrix, anddasani et al., 1995b). Recently, it has been reported that
AML1 is expressed in ECs in sites where early HSCs transmigrate through the basement membrane of capil-
lary ECs into parenchymal cells. Therefore, we hypothe-are thought to emerge, such as the yolk sac, vitelline
and umbilical arteries, and the dorsal aorta in the AGM size that FN production on the intraluminal surface of
ECs is the initial step in migration of HSCs and ECs.region (North et al., 1999). An autonomous effect in ECs
by AML1 gene disruption has been suggested to cause Ang1 and VEGF may have important clinical applica-
tions in treatment of ischemia because of their stronghemorrhage; however, AML1 expression in ECs is not
observed in the brain and heart where severe abnormali- angiogenic effects observed in cornea assays and trans-
genic mice. (Asahara et al., 1998; Suri et al., 1998). Solu-ties in angiogenesis are observed in AML1 deficient em-
bryos. Impaired angiogenesis in AML1 mutants was ble Ang1 rescues network formation in AML1 mutant
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anti-CD4, -CD8, and Ly-76 was used as a lineage marker (Lin). Alsomice in vitro; however, HSCs from embryos and adult
used was anti-TIE2 (TEK4). All mAbs were purified and conjugatedmice could promote vascular network formation more
with FITC, PE, or biotin. Biotinylated antibodies were visualized witheffectively than soluble Ang1. In transgenic mice ex-
PE- (GIBCO BRL), FITC- (Sigma), or APC- (Caltag, Burlingame, CA)pressing Ang1 in the skin under control of the K14 kera-
conjugated streptavidin. The stained cells were analyzed and sorted
tinocyte specific promoter, hypervascularity was ob- by FACSvantage (Becton Dickinson, San Jose, CA).
served in the dermis but not in other organs, indicating
a localized effect of Ang1 (Suri et al., 1998). Administra- Limiting Dilution Assay
tion of Ang1 results in widespread stimulation of TIE21 Sorted cells were cultured on OP9 cells in the media as described
ECs, while HSCs may promote localized angiogenesis. in P-Sp culture. Cultures were scaled down to 20, 10, 5, 3, 2, 1, and
Therefore, findings presented here may have important 0.5 in 0.1 ml for a limiting dilution assay. When the recovered cells
are composed of at least three lineages, such as erythroid, myeloid,clinical applications.
and lymphoid cells, we score these as positive wells containing
multipotential hematopoietic progenitors.Experimental Procedures
Animals RT-PCR Analysis
C57BL/6 mice were purchased from Japan SLC (Shizuoka, Japan). Procedures for RT-PCR analysis have been described elsewhere
AML1, c-Myb, or Ang1 mutant mice were generated as described (Takakura et al., 1998). Sequences of specific primers used in RT-
(Mucenski et al., 1991, Suri et al., 1996; Okada et al., 1998). Trans- PCR of mAng1 and mb actin were as described (Takakura et al.,
genic mice with GFP (gift from Dr. M. Okabe, Osaka University, 1998).
Osaka, Japan) were generated as described (Okabe et al., 1997). To amplify mVEGF and LacZ, forward primer was 59CTTCCT
Animal care in our laboratory was in accordance with the guidance of ACAGCACAGCAGATGTGAA39 and the reverse was 59TGGTGACA
Kumamoto University for animal and recombinant DNA experiments. TGGTTAATCGGTCTTTC39 for VEGF, and forward primer was
59GCGTTACCCAACTTAATCG39, and the reverse was 59 TGTGAGC
GAGTAACAACC39 for LacZ, respectively. Each cycle consisted ofIn Vitro Culture of P-Sp and Hematopoietic Progenitors
P-Sp culture conditions were as described (Takakura et al., 1998). a 30 s denaturation at 948C, 2 min of annealing at 648C, and a 2 min
extension at 728C.In brief, P-Sp explants of E9.5 embryos were cultured on OP9 stro-
mal cells (Nakano et al., 1994) in RPMI1640 (GIBCO BRL, Gaithers-
burg, MD) with 10% fetal calf serum (FCS; JRH Bioscience, Lenexa, In Vivo Neovascularization Using Matrigel
KS) and 1025 M 2ME (Sigma, St. Louis, MO) supplemented with IL-6 Preparation, injection, and processing of matrigel (Becton Dickin-
(20 ng/ml), IL-7 (20 ng/ml) (gifts from Dr. T. Sudo, Toray Industries son, Bedford, MA) were as described (Passaniti et al., 1992) with
Inc., Kamakura, Japan), SCF (50 ng/ml) (a gift from Chemo-Sero- some modifications. Briefly, 8-week-old C57BL mice were injected
Therapeutic Co., Ltd., Kumamoto, Japan), and Epo (2 U/ml) (a gift subcutaneously with 0.5 ml matrigel and 37 units heparin/ml (Sigma),
from Snow-Brand Milk Product Co, Tochigi, Japan) at 378C in humid- 20 ng VEGF/ml (Pepro Tec, London, UK), 50 ng SCF /ml, and 2x104
ified 5% CO2 air. 3x102 sorted HSCs were added to P-Sp cultures LinÐc-Kit1Sca-11 cells from the bone marrow of 8-week-old C57BL
4 days after initiation of the culture. 300 ng/ml Ang1* (a gift from mice in the presence or absence of soluble TIE2 receptors (20 mg/
Dr. G. D. Yancopoulos, Regeneron Pharmaceuticals, Inc., Tarrytown, ml), or CD4-Fc chimeric protein as a control (20 mg/ml) near the
NY) was added to P-Sp cultures of wt and AML1 mutant embryos. abdominal midline using a 25-guage needle. HSCs were labeled
Ang1 used in in vitro studies was a recombinant version of Ang1 with PKH26 (PKH26 red fluorescent cell linker mini kit, Sigma) before
with a modified NH2 terminus and mutated Cys245 and has been mixing with matrigel. Matrigels were dissected on day 4 from mice,
designated Ang1* (Maisonpierre et al., 1997). and gel sections were stained with FITC-conjugated anti-PECAM-1
The in vitro colony assay for hematopoietic progenitors was per- mAb (Pharmingen).
formed as described previously (Takakura et al., 1996).
Cell Migration Assay
Immunohistochemistry EC migration assays were performed using a 48-well microchemo-
An anti-PECAM-1 antibody (MEC13.3, Pharmingen, San Diego, CA), taxis chamber (Neuroprobe). Tweny-five microliters of Ang1* diluted
anti-Flk-1 antibody (AVAS12a1,Pharmingen), anti-TIE2 antibody in serum free media (SA, a gift from Chemo-Sero-Therapeutic Co.,
(TEK4) (Yano et al., 1997), horseradish peroxidase (HRP)-conjugated Ltd) or sorted HCs suspended in SA (104/ml or 105/ml) in the presence
anti-a smooth muscle actin antibody (1A4, DAKO, Glustrup, Den- or absence of CD4-Fc, TIE2-Fc, Flk-1-Fc (Takakura et al., 1998), or
mark), anti-Ang1 antibody (Santa Cruz Biotechnology, Santa Cruz, Ang2 (gift from Dr. G. D. Yancopoulos) were placed in the lower
CA), and anti-CD45 or biotinylated anti-CD45 antibody (30-F11, chamber of a Boyden chamber. After plating polycarbonate filter
Pharmingen), were used for staining of tissues. First antibodies were with a pore size of 5 mm (Nucleopore; Costar, Cambridge, MA)
developed with HRP-conjugated anti-rat or anti-goat Ig antibody between lower and upper chamber, 4x102 sorted ECs suspended
(Biosource, Camarillo, CA), respectively. Biotinylated antibodies in 50 ml of SA medium containing 0.5% BSA were seeded in the
were developed with alkaline phosphatase (ALP) conjugated strep- upper compartment. The migrated cells were counted under micro-
tavidin (DAKO). Diaminobenzidine (DAB; Dojin Chem., Kumamoto, scope after staining with Giemsa solution.
Japan) or 3-amino-9-ethyl carbazole (AEC; DAKO) was used for the
HRP color reaction. New fuchsin (DAKO) or 5-bromo-4-chloro-3-
Acknowledgmentsindoxyl phosphate/ nitro blue tetrazolium chloride (BCIP/NBT; Boeh-
ringer Mannheim, Mannheim, Germany) was used for the ALP color
We thank Drs. Michael L. Mucenski, Masaru Okabe, and G. D. Yan-reaction. Procedures for immunohistochemistry have been de-
chopoulos for providing us with c-Myb mutant mice, GFP transgenicscribed elsewhere (Takakura et al., 1998).
mice, and Ang1 mutant mice, respectively. This work was supported
in part by grants-in-aid for scientific research (06277104 and
Cell Preparation and Flow Cytometry
10470211) from the Ministry of Education, Science, and Culture of
Embryos were staged by somite counting. AGM or P-Sp was isolated
Japan.
using the methods described (Godin et al., 1995). Methods for cell
preparation were as described previously (Takakura et al., 1998).
Received November 17, 1999; revised June 1, 2000.The cell-staining procedure for flow cytometry was as described
previously (Takakura et al., 1996). The mAbs used in immunofluores-
Referencescence staining were anti-CD45, -CD34, -c-Kit (2B8), -PECAM-1,
-Sca-1 (E13±161.7), Mac-1 (M1/70), Gr-1 (RB6±8C5), B220 (RA3±6B2),
anti-CD4 (L3T4), -CD8 (53±6.72), and Ly-76 (TER-119), all of which Asahara, T., Chen, D., Takahashi, T., Fujikawa, K., Kearney, M.,
Magner, M., Yancopoulos, G.D., and Isner, J.M. (1998). Tie2 receptorwere purchased from Pharmingen. A mixture of Mac-1, Gr-1, B220,
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